MTD · NYSE · Medical - Diagnostics & Research

Mettler-Toledo (MTD)

Precision instruments, inspection systems, and services for laboratories, factories, logistics, and food retail.

$1,498.87
vs last close+68.43 (+4.78%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue9429359269479551,0458849831,0301,1309471,027
Cost of revenue401401396399400424375421440474411397
Gross profit541534530547554621509562589656536631
264270281282276287289297300312310316
Research & development464646464750464951535153
Selling, general & administrative217223234236229237243247248260258263
Operating income278264249266278334220266290343227314
−26−31−29−23−19−19−18−17−21−14−17−25
Interest expense202019191918171718171717
Other non-operating income400000000000
Income before tax251233221243259315202249269329210289
Income tax expense504843214762384652434057
Net income from continuing operations202185178222212252164202217286169233
Net income202185178222212252164202217286169233
EPS, basic$9.26$8.56$8.28$10.42$10.01$12.00$7.84$9.78$10.60$14.02$8.35$11.57
EPS, diluted$9.21$8.52$8.24$10.37$9.96$11.96$7.81$9.76$10.57$13.98$8.33$11.55
Weighted average shares, basic222221212121212121202020
Weighted average shares, diluted222222212121212121202020
EBITDA305294280296309365249296323376259347
Depreciation & amortization313131313131303033333333
EBIT274264249266278334220266290343227314